Tsu LV - Search Results

1

Considerations for Systemic Anticoagulation in ESRD.

Dager WE, Tsu LV, Pon TK. Dager WE, et al. Among authors: tsu lv. Semin Dial. 2015 Jul-Aug;28(4):354-62. doi: 10.1111/sdi.12376. Epub 2015 May 7. Semin Dial. 2015. PMID: 25951901 Review.

2

Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy.

Nagle EL, Tsu LV, Dager WE. Nagle EL, et al. Among authors: tsu lv. Ann Pharmacother. 2011 Sep;45(9):e47. doi: 10.1345/aph.1P785. Epub 2011 Aug 23. Ann Pharmacother. 2011. PMID: 21862711

3

Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.

Tsu LV, Dager WE. Tsu LV, et al. Ann Pharmacother. 2011 Oct;45(10):1185-92. doi: 10.1345/aph.1Q177. Epub 2011 Aug 31. Ann Pharmacother. 2011. PMID: 21881032

4

Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia.

Tsu LV, Dager WE. Tsu LV, et al. Pharmacotherapy. 2012 Jan;32(1):20-6. doi: 10.1002/PHAR.1016. Pharmacotherapy. 2012. PMID: 22392825

5

Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.

Tsu LV, Dienes JE, Dager WE. Tsu LV, et al. Ann Pharmacother. 2012 Dec;46(12):1617-26. doi: 10.1345/aph.1R497. Epub 2012 Dec 18. Ann Pharmacother. 2012. PMID: 23249867

6

Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.

Tsu LV, Dager WE. Tsu LV, et al. Ann Pharmacother. 2013 Apr;47(4):573-7. doi: 10.1345/aph.1R576. Epub 2013 Apr 2. Ann Pharmacother. 2013. PMID: 23548645 Review.

7

Use of ranolazine in the prevention and treatment of postoperative atrial fibrillation in patients undergoing cardiac surgery.

Tsu LV, Lee S. Tsu LV, et al. Ann Pharmacother. 2014 May;48(5):633-7. doi: 10.1177/1060028014523257. Epub 2014 Feb 12. Ann Pharmacother. 2014. PMID: 24523397 Review.

8

Modified HAS-BLED Score and Risk of Major Bleeding in Patients Receiving Dabigatran and Rivaroxaban: A Retrospective, Case-Control Study.

Tsu LV, Berry A, Wald E, Ehrlich C. Tsu LV, et al. Consult Pharm. 2015 Jul;30(7):395-402. doi: 10.4140/TCP.n.2015.395. Consult Pharm. 2015. PMID: 26173191

9

Direct-acting oral anticoagulants in patients with atrial fibrillation and valvular heart disease.

Canales N, Cao T, Fakourfar N, Snee M, Tsu L. Canales N, et al. JAAPA. 2022 Sep 1;35(9):17-18. doi: 10.1097/01.JAA.0000854516.90788.a8. JAAPA. 2022. PMID: 36007114

10

Managing acute coronary syndromes in the elderly.

Carroll KA, Early NK, Tsu LV. Carroll KA, et al. Among authors: tsu lv. Consult Pharm. 2015 May;30(5):265-82. doi: 10.4140/TCP.n.2015.265. Consult Pharm. 2015. PMID: 25979126 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page